Back to School: How biopharma can reboot drug development. Access exclusive analysis here

First Horizon acquires two Andrx drugs

FHRX will acquire U.S. rights to Fortamet extended-release metformin and Altoprev

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE